These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24565527)

  • 1. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-based characterization of drug-protein interaction signatures with a space-efficient approach.
    Tabei Y; Kotera M; Sawada R; Yamanishi Y
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):39. PubMed ID: 30953486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.
    Tabei Y; Pauwels E; Stoven V; Takemoto K; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i487-i494. PubMed ID: 22962471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global optimization-based inference of chemogenomic features from drug-target interactions.
    Zu S; Chen T; Li S
    Bioinformatics; 2015 Aug; 31(15):2523-9. PubMed ID: 25819672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting drugs side effects based on chemical-chemical interactions and protein-chemical interactions.
    Chen L; Huang T; Zhang J; Zheng MY; Feng KY; Cai YD; Chou KC
    Biomed Res Int; 2013; 2013():485034. PubMed ID: 24078917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relating drug-protein interaction network with drug side effects.
    Mizutani S; Pauwels E; Stoven V; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i522-i528. PubMed ID: 22962476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.
    Yang L; Chen J; He L
    PLoS Comput Biol; 2009 Jul; 5(7):e1000441. PubMed ID: 19629158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Potential Drug-Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features.
    Xuan P; Song Y; Zhang T; Jia L
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting drug targets based on protein domains.
    Wang YY; Nacher JC; Zhao XM
    Mol Biosyst; 2012 Apr; 8(5):1528-34. PubMed ID: 22402667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferring Chemogenomic Features from Drug-Target Interaction Networks.
    Yamanishi Y
    Mol Inform; 2013 Dec; 32(11-12):991-9. PubMed ID: 27481144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug-gene interactions and adverse drug reactions.
    Malki MA; Pearson ER
    Pharmacogenomics J; 2020 Jun; 20(3):355-366. PubMed ID: 31792369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug target prediction using adverse event report systems: a pharmacogenomic approach.
    Takarabe M; Kotera M; Nishimura Y; Goto S; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i611-i618. PubMed ID: 22962489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical basis of pharmacology.
    Keiser MJ; Irwin JJ; Shoichet BK
    Biochemistry; 2010 Dec; 49(48):10267-76. PubMed ID: 21058655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-domain interaction networks in myocardial infarction.
    Wang H; Zheng H; Azuaje F; Zhao XM
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):182-8. PubMed ID: 23974657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PG-path: Modeling and personalizing pharmacogenomics-based pathways.
    Hong JY; Kim JH
    PLoS One; 2020; 15(5):e0230950. PubMed ID: 32365122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disease-drug-phenotype matrix inferred by walking on a functional domain network.
    Fang H; Gough J
    Mol Biosyst; 2013 Jul; 9(7):1686-96. PubMed ID: 23462907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug target identification using side-effect similarity.
    Campillos M; Kuhn M; Gavin AC; Jensen LJ; Bork P
    Science; 2008 Jul; 321(5886):263-6. PubMed ID: 18621671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear and Kernel Model Construction Methods for Predicting Drug-Target Interactions in a Chemogenomic Framework.
    Yamanishi Y
    Methods Mol Biol; 2018; 1825():355-368. PubMed ID: 30334213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.